Heterocyclic compounds and their use as PARP inhibitors

US7041675B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Wilfried Lubisch · Mannheim, DE
• Michael Andreas Kock · Schifferstadt, DE
• Thomas Hoeger · Edingen-Neckarhausen, DE
• Roland Grandel · Dossenheim, DE
• Reinhold Mueller · Schifferstadt, DE
• Sabine Schult · Speyer, DE

Key dates

• Filing date: Jan 25, 2001
• Grant date: May 9, 2006
• Expiry date: Jan 25, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of the formula I and the tautomeric forms, possible enantiomeric and diasteromeric forms thereof, and prodrugs thereof, and use thereof as PARP inhibitors.